MMJ International Holdings, an FDA IND-stage pharmaceutical cannabinoid developer, is a plaintiff in landmark litigation ...

New data demonstrate that transgenic American chestnuts produce significantly smaller blight cankers than their wild-type counterparts MCGRAW, NY / ACCESS Newswire / April 25, 2026 / Today, SilvaBio, ...

Can CMS put cannabinoids into Medicare for reimbursement without FDA approval, without safety analysis, and without public rule making?" stated Duane Boise, CEO MMJ International Holdings. WASHINGTON, ...

PharmaNest, a leader in high-resolution single-fiber digital pathology and AI, will present five communications at Digestive Disease Week (DDW) 2026, showcasing its advanced technologies for the study ...

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged ...

Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory ...

UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) announces today that the company's annual and sustainability report for 2025 is published and ...

Dr. Martin explains the role of biological age, NAD levels, and advanced diagnostics in guiding long-term health strategies. MIAMI BEACH, FL / ACCESS Newswire / April 24, 2026 / Dr. Alonso Martin, ...

Iridius, a compliance-by-design AI platform for regulated workflow execution, today announced it has raised $8.6 million in seed funding led by Chalfen Ventures, with participation from Osage Venture ...

"The Senior Care Influencer" joins forces with the free AI platform bringing caregivers immediate support, guidance, and hope. PHOENIX, AZ / ACCESS Newswire / April 24, 2026 / CaregiverCompanion.ai, ...

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases ...

Eurofins Scientific SE (the “Company”) (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of ...